| Post-acute COVID-19 syndrome A Nalbandian, K Sehgal, A Gupta, MV Madhavan, C McGroder, ... Nature medicine 27 (4), 601-615, 2021 | 4738 | 2021 |
| Abatacept in early diffuse cutaneous systemic sclerosis: results of a phase II investigator‐initiated, multicenter, double‐blind, randomized, placebo‐controlled trial D Khanna, C Spino, S Johnson, L Chung, ML Whitfield, CP Denton, ... Arthritis & rheumatology 72 (1), 125-136, 2020 | 210 | 2020 |
| Global skin gene expression analysis of early diffuse cutaneous systemic sclerosis shows a prominent innate and adaptive inflammatory profile B Skaug, D Khanna, WR Swindell, ME Hinchcliff, TM Frech, VD Steen, ... Annals of the rheumatic diseases 79 (3), 379-386, 2020 | 136 | 2020 |
| Belimumab for the treatment of early diffuse systemic sclerosis: results of a randomized, double‐blind, placebo‐controlled, pilot trial JK Gordon, V Martyanov, JM Franks, EJ Bernstein, J Szymonifka, C Magro, ... Arthritis & rheumatology 70 (2), 308-316, 2018 | 126 | 2018 |
| Systemic sclerosis–associated interstitial lung disease: How to incorporate two food and drug administration–approved therapies in clinical practice D Khanna, A Lescoat, D Roofeh, EJ Bernstein, EA Kazerooni, MD Roth, ... Arthritis & Rheumatology 74 (1), 13-27, 2022 | 99 | 2022 |
| Nephrogenic systemic fibrosis: a systemic fibrosing disease resulting from gadolinium exposure EJ Bernstein, C Schmidt-Lauber, J Kay Best Practice & Research Clinical Rheumatology 26 (4), 489-503, 2012 | 95 | 2012 |
| Survival of adults with systemic sclerosis following lung transplantation: a nationwide cohort study EJ Bernstein, ER Peterson, JL Sell, F D'Ovidio, SM Arcasoy, JM Bathon, ... Arthritis & rheumatology 67 (5), 1314-1322, 2015 | 88 | 2015 |
| COVID-19 and systemic lupus erythematosus: a case series Y Gartshteyn, AD Askanase, NM Schmidt, EJ Bernstein, L Khalili, R Drolet, ... The Lancet Rheumatology 2 (8), e452, 2020 | 74 | 2020 |
| HLA and autoantibodies define scleroderma subtypes and risk in African and European Americans and suggest a role for molecular mimicry P Gourh, SA Safran, T Alexander, SE Boyden, ND Morgan, AA Shah, ... Proceedings of the National Academy of Sciences 117 (1), 552-562, 2020 | 65 | 2020 |
| Rheumatoid arthritis-associated autoantibodies and subclinical interstitial lung disease: the Multi-Ethnic Study of Atherosclerosis EJ Bernstein, RG Barr, JHM Austin, SM Kawut, G Raghu, JL Sell, ... Thorax 71 (12), 1082-1090, 2016 | 65 | 2016 |
| Expert consensus on the management of systemic sclerosis-associated interstitial lung disease FF Rahaghi, VM Hsu, RJ Kaner, MD Mayes, IO Rosas, R Saggar, ... Respiratory research 24 (1), 6, 2023 | 64 | 2023 |
| High-attenuation areas on chest computed tomography and clinical respiratory outcomes in community-dwelling adults AJ Podolanczuk, EC Oelsner, RG Barr, EJ Bernstein, EA Hoffman, ... American journal of respiratory and critical care medicine 196 (11), 1434-1442, 2017 | 64 | 2017 |
| Screening high resolution computed tomography of the chest to detect interstitial lung disease in systemic sclerosis: a global survey of rheumatologists EJ Bernstein, D Khanna, DJ Lederer Arthritis & Rheumatology (Hoboken, NJ) 70 (6), 971, 2018 | 54 | 2018 |
| Generation of a core set of items to develop classification criteria for scleroderma renal crisis using consensus methodology EA Butler, M Baron, AB Fogo, T Frech, C Ghossein, E Hachulla, S Hoa, ... Arthritis & rheumatology 71 (6), 964-971, 2019 | 52 | 2019 |
| Proceedings of the American College of Rheumatology/Association of Physicians of Great Britain and Ireland Connective Tissue Disease–associated interstitial lung disease summit … A Fischer, ME Strek, V Cottin, PF Dellaripa, EJ Bernstein, KK Brown, ... QJM: An International Journal of Medicine 112 (2), 81-93, 2019 | 52 | 2019 |
| Clinical characteristics, visceral involvement, and mortality in at-risk or early diffuse systemic sclerosis: a longitudinal analysis of an observational prospective … S Jaafar, A Lescoat, S Huang, J Gordon, M Hinchcliff, AA Shah, S Assassi, ... Arthritis research & therapy 23 (1), 170, 2021 | 48 | 2021 |
| Changes in mental health symptoms from pre-COVID-19 to COVID-19 among participants with systemic sclerosis from four countries: A Scleroderma Patient-centered Intervention … BD Thombs, L Kwakkenbos, RS Henry, ME Carrier, S Patten, S Harb, ... Journal of Psychosomatic Research 139, 110262, 2020 | 47 | 2020 |
| Performance characteristics of pulmonary function tests for the detection of interstitial lung disease in adults with early diffuse cutaneous systemic sclerosis EJ Bernstein, S Jaafar, S Assassi, RT Domsic, TM Frech, JK Gordon, ... Arthritis & Rheumatology 72 (11), 1892-1896, 2020 | 46 | 2020 |
| Protocol for a partially nested randomised controlled trial to evaluate the effectiveness of the scleroderma patient-centered intervention network COVID-19 home-isolation … BD Thombs, L Kwakkenbos, ME Carrier, A Bourgeault, L Tao, S Harb, ... Journal of psychosomatic research 135, 110132, 2020 | 43 | 2020 |
| Safety and efficacy of abatacept in early diffuse cutaneous systemic sclerosis (ASSET): open-label extension of a phase 2, double-blind randomised trial L Chung, C Spino, R McLain, SR Johnson, CP Denton, JA Molitor, ... The Lancet Rheumatology 2 (12), e743-e753, 2020 | 37 | 2020 |
Dinesh KhannaProfessor of Medicine, University of Medicine在 umich.edu 的电子邮件经过验证
